Dr. Dae Wook , Takeda Pharmaceuticals Ltd Pte Asia-Pacific Region-south korea | Best Research Award
Dr. Dae Wook Lee is a Head of Medical Portfolio Management in Rare ...
Dr. Dae Wook Lee is a Head of Medical Portfolio Management in Rare disease, Gastroenterology, PDT, Neuroscience and New Molecular entities from Asia-Pacific Region of Takeda Pharmaceutical Ltd Pte. He ...obtained his Medical degree from the University of Warwick, U.K. awarded MbChB Medicine & Surgery, and completed MSC Genetic Epidemiology at the Medical Research Unit in the University of Sheffield, U.K with additional BSc Biomedical Science degree.
Dr. Dae Wook Lee’s main clinical research interests lie in genetics and novel medical statistical analysis of Rare Diseases including Rare Hematology, Rare Metabolic Diseases including Fabry & Gaucher’s Disease, Rare Immunology including Hereditary AngioEdema (HAE), etiology and pathophysiology of inflammatory bowel disease (IBD), and Rare Neuroscience disease including Paediatric Epilepsy and Narcolepsy Type 1. One of his recent publications include Network Meta-analysis of Comparative Efficacy and Safety of Combination Therapy with Angiotensin II Receptor Blockers and Amlodipine in Asian Hypertensive Patients, and Retrospective analysis of Ulcerative Colitis Real-world Evidence implementing exploratory Propensity Score Matching (PSM) Analysis. Dr. Dae Wook Lee is also a member of Korean Society of Pharmaceutical Medicine (KSPM).Show More